Based on the finding that AP-1 binding sites are broadly opened in KYSE-30 cells, we postulated that inhibiting AP-1-DNA binding may reduce the cancer cell characteristics, such as proliferation and migration, of KYSE-30 cells. The gene discussed is FOS; the disease is cancer.